🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out whether the combination of botensi...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2025-02-20
Trial ID
NCT06843434
Treatments Being Tested
This is a phase I, open label, plus expansion clinical trial evaluating the...
Status
Recruiting
Location
Children's Health Orange County (CHOC)
Start Date
2022-01-10
Trial ID
NCT04943848
Treatments Being Tested
This study is an open-label, Phase 1 study to evaluate the safety, tolerabi...
Status
Terminated
Location
HonorHealth Research Institute
Start Date
2019-12-10
Trial ID
NCT04156100
Treatments Being Tested
This is an open-label, non-randomized, single-institution, single arm Phase...
Status
Active Not Recruiting
Location
University of Colorado Hospital
Start Date
2020-01-28
Trial ID
NCT04028063
Treatments Being Tested
Adenoid cystic carcinoma (AdCC) is a rare salivary gland malignant tumor th...
Status
Terminated
Location
Hôpital Saint-André (Chu de Bordeaux)
Start Date
2023-11-29
Trial ID
NCT05930951
Treatments Being Tested
Participants will receive study treatment with agenT-797, botensilimab, bal...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2024-02-01
Trial ID
NCT06251973
Treatments Being Tested
This is an open-label, multi-center Phase II clinical trial to assess the e...
Status
Withdrawn
Location
Betta Clinical Study Site 4
Start Date
2021-10-01
Trial ID
NCT05033132
Treatments Being Tested
This is an open-label, Phase 1, 2-part trial to determine recommended phase...
Status
Completed
Location
USC Norris Comprehensive Cancer Center
Start Date
2022-07-19
Trial ID
NCT05377528
Treatments Being Tested
The purpose of this study is to determine the optimal dose of AGEN2373 that...
Status
Recruiting
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2025-05-27
Trial ID
NCT06782932
Treatments Being Tested
This is a window-of-opportunity umbrella platform trial enrolling non-metas...
Status
Recruiting
Location
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Start Date
2023-05-11
Trial ID
NCT05845450